Guillermo L Chantada Selected Research

Topotecan (Hycamtin)

10/2017	Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
1/2017	OCULAR PHARMACOLOGY OF CHEMOTHERAPY FOR RETINOBLASTOMA.
10/2016	Sustained-release hydrogels of topotecan for retinoblastoma.
1/2016	Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells.
9/2014	Ocular pharmacology of topotecan and its activity in retinoblastoma.
4/2014	Clinical pharmacokinetics of intra-arterial melphalan and topotecan combination in patients with retinoblastoma.
5/2013	Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
3/2013	Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
6/2012	Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients.
4/2010	Episcleral implants for topotecan delivery to the posterior segment of the eye.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guillermo L Chantada Research Topics

Disease

36	Retinoblastoma (Glioblastoma, Retinal) 11/2022 - 03/2004
23	Neoplasms (Cancer) 01/2022 - 07/2007
5	Neuroblastoma 12/2021 - 03/2004
4	Sepsis (Septicemia) 01/2018 - 03/2010
3	Disease Progression 10/2021 - 03/2010
3	Neoplasm Metastasis (Metastasis) 11/2019 - 07/2007
3	Neutropenia 01/2018 - 05/2013
3	Margins of Excision 11/2014 - 02/2009
2	Edema (Dropsy) 01/2018 - 04/2009
1	COVID-19 10/2021
1	Necrosis 01/2019
1	Thrombosis (Thrombus) 01/2018
1	Fever (Fevers) 01/2018
1	Hypotension (Low Blood Pressure) 01/2018
1	Bradycardia 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Melanoma (Melanoma, Malignant) 11/2017
1	Sarcoma (Soft Tissue Sarcoma) 11/2017
1	Neurilemmoma (Schwannoma) 11/2017
1	Lymphoma (Lymphomas) 11/2017
1	Toxic Optic Neuropathy 10/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Body Weight (Weight, Body) 04/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2012
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2012
1	Renal Insufficiency (Renal Failure) 10/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2012
1	Vomiting 04/2009
1	Herpes Simplex 07/2007
1	Medulloblastoma 03/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2004

Drug/Important Bio-Agent (IBA)

13	Topotecan (Hycamtin)FDA LinkGeneric 10/2017 - 03/2004
6	Pharmaceutical PreparationsIBA 01/2022 - 03/2004
6	Melphalan (Alkeran)FDA LinkGeneric 01/2018 - 06/2012
5	Messenger RNA (mRNA)IBA 12/2016 - 03/2010
4	Carboplatin (JM8)FDA LinkGeneric 11/2022 - 07/2007
4	(N- acetylneuraminyl)- galactosylglucosylceramide N-acetylgalactosaminyltransferaseIBA 01/2019 - 03/2010
4	Retinaldehyde (Retinal)IBA 11/2017 - 03/2013
2	Etoposide (VP 16)FDA LinkGeneric 11/2022 - 03/2004
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 12/2016 - 07/2015
2	racotumomabIBA 01/2016 - 12/2015
2	GangliosidesIBA 12/2015 - 03/2010
2	GD2 gangliosideIBA 09/2013 - 03/2010
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2022
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2022
1	CytokinesIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Macrophage Migration-Inhibitory FactorsIBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	dinutuximabIBA 12/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	ParaffinIBA 01/2020
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Pantoprazole (Protonix)FDA LinkGeneric 10/2017
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 01/2017
1	HydrogelsIBA 10/2016
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 10/2016
1	GlycoconjugatesIBA 01/2016
1	aluminum sulfate (alum)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	VaccinesIBA 12/2015
1	Digoxin (Digitek)FDA LinkGeneric 07/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2012
1	CreatinineIBA 10/2012
1	Phosphates (Orthophosphate)IBA 10/2012
1	LactonesIBA 04/2010
1	EnzymesIBA 03/2010
1	Ondansetron (Zofran)FDA LinkGeneric 04/2009
1	Phosphotransferases (Kinase)IBA 07/2007
1	Ganciclovir (Cytovene)FDA LinkGeneric 07/2007

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 11/2022 - 03/2004
12	Therapeutics 11/2022 - 05/2005
7	Radiotherapy 11/2022 - 07/2010
5	Conservative Treatment 01/2022 - 05/2014
3	Immunotherapy 01/2022 - 12/2015
3	Intravitreal Injections 01/2018 - 09/2014
3	Adjuvant Chemotherapy 11/2014 - 07/2007
2	Injections 01/2018 - 03/2013
2	Cryotherapy (Therapy, Cold) 01/2018 - 07/2007
2	Intraocular Injections 05/2013 - 08/2007
1	Stem Cell Transplantation 10/2021
1	Neoadjuvant Therapy 01/2018
1	Anesthesia 01/2018
1	Induction Chemotherapy 07/2015
1	Salvage Therapy 05/2013
1	Aftercare (After-Treatment) 10/2012
1	Intravenous Infusions 08/2007
1	Induced Hyperthermia (Thermotherapy) 07/2007
1	Brachytherapy 07/2007
1	Light Coagulation 07/2007
1	Lasers (Laser) 07/2007